Home › NDC Lookup › Ingredients › Octinoxate › 82715-0106-14
GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 Octinoxate 1 g/100mL Lotion, 30 mL — NDC 82715-0106-14 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 Octinoxate 1 g/100mL Lotion, 30 mL — NDC 82715-106-14 (Billing 82715-0106-14)

by ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI · 30 mL in 1 TUBE

This is a package of 30 mL of GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 Octinoxate 1 g/100mL Lotion from ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI, marketed since Jul 2022 and currently FDA-listed, this package's marketing is listed to end Jul 2029.

NDC 82715-0106-14
🏷️ FDA NDC (as labeled) 82715-106-14 billing pads the product segment with a zero
This package
Contains30 mL Pack sizes25 compare ↓
Product page 82715-0106-01 Also comes in: 30 ml 82715-106-01 30 ml 82715-106-02 30 ml 82715-106-03 30 ml 82715-106-04 30 ml 82715-106-05 30 ml 82715-106-06 30 ml 82715-106-07 30 ml 82715-106-08 30 ml 82715-106-09 30 ml 82715-106-10 30 ml 82715-106-11 30 ml 82715-106-12 30 ml 82715-106-13 30 ml 82715-106-15 30 ml 82715-106-16 30 ml 82715-106-17 30 ml 82715-106-18 30 ml 82715-106-19 30 ml 82715-106-20 30 ml 82715-106-21 30 ml 82715-106-22 30 ml 82715-106-23 30 ml 82715-106-24 30 ml 82715-106-25
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 82715-106-14 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
82715 labeler · 106 product · 14 package
Package marketed since
Jul 22, 2022
Package marketing ended
Jul 31, 2029
Sample package
No — commercial package
Barcode (UPC)
8691190963613
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 82715-106-14
Product NDC 82715-106
11-digit billing NDC 82715010614
UNII 4Y5P7MUD51
UPC 8691190963613
Application # M020
SPL Set ID 038ec45a-0d56-4cd9-8060-767b382c1237
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-07-22
Marketing end 2029-07-31
Route TOPICAL
Dosage form LOTION
Substance OCTINOXATE
Why two NDCs? The FDA registers this code as 82715-106-14 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82715-0106-14. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an over-the-counter lotion that combines foundation and concealer in one product. It contains octinoxate, a chemical sunscreen ingredient that is typically used to help filter ultraviolet (UV) rays and protect skin from sun exposure. The product is applied topically to the face and includes SPF 15, indicating a modest level of sun protection. This product is marketed under the FDA's OTC monograph rules for sunscreen and cosmetic products rather than as an individually reviewed drug application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml 30 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
82715-0106-01 82715-106-01 Main listing 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-02 82715-106-02 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-03 82715-106-03 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-04 82715-106-04 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-05 82715-106-05 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-06 82715-106-06 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-07 82715-106-07 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-08 82715-106-08 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-09 82715-106-09 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-10 82715-106-10 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-11 82715-106-11 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-12 82715-106-12 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-13 82715-106-13 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-14 You're viewing this 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-15 82715-106-15 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-16 82715-106-16 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-17 82715-106-17 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-18 82715-106-18 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-19 82715-106-19 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-20 82715-106-20 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-21 82715-106-21 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-22 82715-106-22 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-23 82715-106-23 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-24 82715-106-24 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active
82715-0106-25 82715-106-25 30 mL in 1 TUBE 2022-07-22 Jul 31, 2029 Active

Pack size FAQ

What quantity is in this package?
This package contains 30 mL — 30 ml in 1 tube.
How does this package differ from NDC 82715-0106-01?
Both are GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 Octinoxate 1 g/100mL Lotion — the drug itself is identical. This page's package is the 30 mL one, while NDC 82715-0106-01 is the 30 ml package.
What NDC number is used to bill for this package of GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 Octinoxate 1 g/100mL Lotion?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 1 g/100mLthis 82715-0106-14 ERKUL 30 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jul 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 9E8X80D2L0
    A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
  • UNII 5QB0T2IUN0
    Aluminum hydroxide is a white powder mineral compound used as an antacid ingredient in some formulations. It works as a buffer and pH regulator to help neutralize stomach acid in the medicine.
  • UNII Q95M2P1KJL
    A silicone-based ingredient that acts as a lubricant and glidant. It helps the tablet or capsule move smoothly through manufacturing equipment and improves powder flow during production.
  • UNII 0THT5PCI0R
    A silicone-based liquid that helps distribute active ingredients evenly throughout topical products. It acts as a solvent and emollient, allowing medicines to spread smoothly on skin while improving texture and absorption.
  • UNII UF7620L1W6
    A synthetic silicone polymer that acts as a thickener and absorbent in medicines. It helps create the right texture, improves how the product feels on skin or in the mouth, and can absorb excess moisture or oil in formulations.
  • UNII 92RU3N3Y1O
    Dimethicone is a silicone-based oil that acts as an anti-foaming agent and lubricant in medicines. It reduces gas bubbles in liquid formulations and helps coat and protect the stomach lining when ingested.
  • UNII 9E4CO0W6C5
    A silicone-based polymer that forms soft, spongy particles. Used as a texture modifier and suspending agent to improve how the product feels and flows, and to help keep ingredients evenly distributed throughout the formulation.
  • UNII X687XDK09L
    A clay mineral processed to carry positive charges, used as a thickener and suspending agent in liquid medicines. It helps keep solid particles evenly distributed throughout the product.
  • UNII 8NLQ36F6MM
    Edetate disodium anhydrous is a chemical compound that binds to metal ions in a medicine. It's used as a stabilizer to prevent unwanted chemical reactions and help keep the drug product effective during storage.
  • UNII 147D247K3P
    Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 1K92T9919H
    A synthetic surfactant derived from cetyl alcohol and ethylene oxide. It helps dissolve and mix oils with water in formulations, acting as an emulsifier and solubilizer to create uniform medicines.
  • UNII A8289P68Y2
    Isododecane is a lightweight liquid hydrocarbon used as a solvent and spreadability agent in topical formulations. It helps dissolve active ingredients and makes the product easier to apply and absorb into the skin.
  • UNII D81QY6I88E
    Linalool is a natural fragrant oil found in plants like lavender and citrus. It's used in medicines as a flavoring agent and to mask unpleasant tastes or smells.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 8PR7V1SVM0
    A silicone-based lubricant combined with polyethylene glycol. It reduces friction and helps the medicine flow smoothly during manufacturing and improves how the product feels when applied or swallowed.
  • UNII 965K72OQXO
    A silicone-based ingredient made from polymers that are chemically linked together. It works as an emulsifier and texture modifier to help blend oil and water components and create a smooth, stable consistency in cosmetic or topical formulations.
  • UNII TYP81E471F
    A silicone-based lubricant and anti-foaming agent derived from dimethicone, a synthetic polymer. It helps reduce friction during tablet or capsule manufacturing and prevents excessive foam in liquid formulations.
  • UNII 9H0AO7T794
    A silicone-based lubricant mixed with polyethylene glycol and polypropylene glycol polymers. It reduces friction between pill surfaces and equipment during manufacturing, and helps the finished product slide smoothly when swallowed.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII DR0K5NOJ4R
    Phenyl trimethicone is a silicone-based lubricant and glidant. It helps powder particles flow smoothly and reduces friction during tablet or capsule manufacturing and filling.
  • UNII X2PZH4Y6HT
    A silicone-based powder derived from silicon and oxygen compounds. It works as a glidant and anti-caking agent to improve how the tablet or capsule flows during manufacturing and prevent clumping in the finished product.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 2PDG9JR76G
    A silicone polymer that serves as a glidant and anti-caking agent in powders and tablets, helping ingredients flow smoothly during manufacturing and preventing clumping in the finished product.
  • UNII EU2PSP0G0W
    Silica dimethyl silylate is a silicon-based powder that acts as a glidant and anti-caking agent. It reduces friction between particles and helps powders flow smoothly during manufacturing and tablet compression.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII LDC331P08E
    A silicone-based compound that acts as a glidant and flow agent in solid medications. It reduces friction between powder particles, helping the medicine flow smoothly during manufacturing and tablet compression.
  • UNII 5041RX63GN
    A synthetic silicon-based polymer used as a glidant and anti-caking agent. It helps powder particles flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.
  • UNII C32PQ86DH4
    Zinc PCA is a zinc salt of pyroglutamic acid, a naturally occurring amino acid derivative. It's used in medications as a skin-conditioning agent and to help maintain product stability and texture in topical formulations.

36 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesWater (Aqua), Cyclopentasiloxane, Dimethicone, Peg-10 Dimethicone, Phenyl Trimethicone, Peg-9 Polydimethylsiloxyethyl Dimethicone, Polymethylsilsesquioxane/Trimethylsiloxysilicate, Caprylyl Methicone, Trımethylsiloxysilicate, Propylene Glycol, Silica Dimethyl Silylate, Disteardimonium Hectorite, Dimethicone/Vinyl Dimethicone Crosspolymer, Polypropylsılsesquioxane, Sodıum Chloride, Zinc Pca, Phenoxyethanol, Silica, Dimethicone Crosspolymer, Peg-12 Dimethicone/Ppg-20 Crosspolymer, Tocopheryl Acetate, Peg/Ppg-18/18 Dimethicone, Talc, Isododecane, Xanthan Gum, Triethoxycaprylylsilane, Titanium Dioxide, Ethylhexylglycerın, Disodium Edta, Isoceteth-10, Fragrance, Magnesium Stearate, Aluminum Hydroxide, Linalool. * Iron Oxides. *contains one or more of these ingredients.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code82715
First marketedJul 2022
Product typeHuman Otc Drug
Portfolio20 products on file

More NDCs from ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI labeler code 82715

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 31 words ▾

Uses • helps prevent sunburn • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

⏱️ Dosage and Administration 116 words ▾

Directions • apply generously 15 minutes before the sun exposure • apply to cleansed skin • can be applied two coats to increase coverage • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating • Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a sun Broad Spectrum SPF value of 15 or higher and other protection measures including: • limit time in the sun, especially from 10 a.m. - 2 p.m. • wear long-sleeved shirts, pants, hats, and sunglasses. • children under 6 months of age: Ask a doctor

⚠️ Warnings 58 words ▾

Warnings For external use only Do not use • on damaged or broken skin When using this product • keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if • rash occurs Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 22 words ▾

Other information • protect the product in this container from excessive heat and direct sun. • store at room temperatures: 15°C- 30°C.

🧪 Active Ingredient 5 words ▾

Active ingredients Octinoxate 1% w/v

🧪 Inactive Ingredients 70 words ▾

Inactive ingredients Water (Aqua), Cyclopentasiloxane, Dimethicone, Peg-10 Dimethicone, Phenyl Trimethicone, Peg-9 Polydimethylsiloxyethyl Dimethicone, Polymethylsilsesquioxane/Trimethylsiloxysilicate, Caprylyl Methicone, Trımethylsiloxysilicate, Propylene Glycol, Silica Dimethyl Silylate, Disteardimonium Hectorite, Dimethicone/Vinyl Dimethicone Crosspolymer, Polypropylsılsesquioxane, Sodıum Chloride, Zinc Pca, Phenoxyethanol, Silica, Dimethicone Crosspolymer, Peg-12 Dimethicone/Ppg-20 Crosspolymer, Tocopheryl Acetate, Peg/Ppg-18/18 Dimethicone, Talc, Isododecane, Xanthan Gum, Triethoxycaprylylsilane, Titanium Dioxide, Ethylhexylglycerın, Disodium Edta, Isoceteth-10, Fragrance, Magnesium Stearate, Aluminum Hydroxide, Linalool. * Iron Oxides. *contains one or more of these ingredients.

🎯 Purpose 2 words ▾

Purpose Sunscreen

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 2 words ▾

Packaging ERKUL-106

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for GR TOTAL COVER 2 in 1 Foundation and Concealer SPF 15 (this brand).

Top reported reactions

Diverticulitis7
Anaphylactic Reaction6
Bronchiectasis6
Bursitis6
Diverticulum Intestinal6
Hypersensitivity6
Hyperthyroidism6

Reporter sex

8 reports
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 5 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI has reported a marketing end date of 2029-07-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 24 other package presentations of this same product, including 30 ml (82715-0106-01), 30 ml (82715-0106-02), 30 ml (82715-0106-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 82715-0105-01 · ERKUL 82715-0107-01 · ERKUL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.